Nuzenio

Obesity Drug Market

Obesity Drug Market news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 15 latest news signals 13 publisher sources 100/100 entity strength

Latest news

Eli Lilly (NYSE: LLY) Files For Next-Gen Weight-Loss Drug Retatrutide In Q1 2027, Leaving Novo Nordisk (NYSE: NVO) Scrambling - foreignpolicyjournal.comforeignpolicyjournal.com · Mon, 10 Aug 2026 00:24:00 GMT Korean aesthetics firms target growing US medspa market amid weight-loss drug boom - KED GlobalKED Global · Sun, 09 Aug 2026 09:58:00 GMT Eli Lilly: 'Strong Buy' On Retatrutide Obesity Drug And EBGLYSS Maintenance Label Expansion - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 22:29:17 GMT The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings - CNBCCNBC · Thu, 06 Aug 2026 13:45:29 GMT Weight loss drug Wegovy made Novo Nordisk Europe’s most valuable company. Finding its next blockbuster drug is proving difficult - FortuneFortune · Thu, 06 Aug 2026 12:31:00 GMT Lilly's GLP-1 Drugs Just Blew Sales Expectations Out Of The Water - Investor's Business DailyInvestor's Business Daily · Wed, 05 Aug 2026 20:07:00 GMT Lilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo - ReutersReuters · Wed, 05 Aug 2026 17:51:09 GMT Lilly Boosts Sales Guidance on Strong Demand for Obesity Drugs - Bloomberg.comBloomberg.com · Wed, 05 Aug 2026 13:38:04 GMT

Timeline

Mon, 10 Aug 2026 00:24:00 GMTEli Lilly (NYSE: LLY) Files For Next-Gen Weight-Loss Drug Retatrutide In Q1 2027, Leaving Novo Nordisk (NYSE: NVO) Scrambling - foreignpolicyjournal.com

Sun, 09 Aug 2026 09:58:00 GMTKorean aesthetics firms target growing US medspa market amid weight-loss drug boom - KED Global

Fri, 07 Aug 2026 22:29:17 GMTEli Lilly: 'Strong Buy' On Retatrutide Obesity Drug And EBGLYSS Maintenance Label Expansion - Seeking Alpha

Thu, 06 Aug 2026 13:45:29 GMTThe divide between Eli Lilly and Novo Nordisk is widening after their latest earnings - CNBC

Thu, 06 Aug 2026 12:31:00 GMTWeight loss drug Wegovy made Novo Nordisk Europe’s most valuable company. Finding its next blockbuster drug is proving difficult - Fortune

Wed, 05 Aug 2026 20:07:00 GMTLilly's GLP-1 Drugs Just Blew Sales Expectations Out Of The Water - Investor's Business Daily

Related explainers

PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

Eli Lilly7 live mentions Lilly5 live mentions NYSE4 live mentions LLY4 live mentions Novo Nordisk4 live mentions GLP4 live mentions Mounjaro4 live mentions CNBC CNBC3 live mentions Yahoo Finance UK3 live mentions Market3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Obesity Drug Market.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

13 distinct publisher/source names are currently connected to this entity page.